Iran has begun the third and final phase of clinical test of domestically produced coronavirus vaccine Razi Cov Pars.
The head of the Razi Institute explained that during the third phase of the clinical trial, researchers will compare the efficacy and immunity produced by the Iranian shot with those of China’s Sinopharm.
Ali Es’haghi said over 40,000 volunteers will take part in this clinical test.
Agriculture Minister Javad Sadati said during a ceremony marking the beginning of the third phase that Iran will produce 20,000,000 doses of the vaccine by the beginning of winter.
“There are currently 1.4 million doses of Razi Cov Pars vaccine at this institute which can be used to start inoculation after authorization for emergency use by the Health Ministry,” the Iranian minister said at the Razi Vaccine and Serum Research Institute in Karaj, near Tehran.
Iran has been domestically producing several coronavirus shots in a bid to combat the outbreak of the respiratory disease.
The Islamic Republic is also producing COVID-19 shots jointly with Cuba, Russia, and Australia.
Iran has also said that it will import between 40 and 50 million vaccine doses in the next two months.
The country is grappling with its fifth wave of the outbreak. Official figures show over 110,000 people have died from the coronavirus in Iran so far.
For the first time in Iran's aviation history, a flight carrying an all-female crew and…
Tehran’s Cyber Police Chief, Brigadier General Davood Moazzami Goudarzi, announced a crackdown on individuals causing…
Doha will stop gas shipments to the EU if member states enforce new legislation on…
At least 15,000 British soldiers left the country's Armed Forces between November 2023 and October…
Journalists have identified the names of 84,761 Russian soldiers who died during the war in…
The United States Navy has inadvertently shot down its own F/A-18 fighter jet in a…